Jump Financial’s Epizyme, Inc EPZM Stock Holding History

Jump Financial’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-29,647	Closed	-$354K	–	1250
2020 Q3	$354K	Buy	+29,647	New	+$397K	0.07%	439

Other funds holding EPZM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Jump Financial's EPZM Position: Q4 2020 in Review

Jump Financial sold out of Epizyme, Inc (EPZM) in Q4 2020, closing a stake of 29,647 shares — an estimated $354K sold.

Jump Financial first reported a position in EPZM in Q3 2020 and held it in 1 quarter. The position peaked at $354K in Q3 2020. 137 funds tracked by Wall St. Rank hold EPZM as of Q4 2020.

Jump Financial reported no remaining Epizyme, Inc position as of Q4 2020 after selling out during the quarter.
Jump Financial sold 29,647 Epizyme, Inc shares in Q4 2020, an estimated $354K.
Jump Financial first reported a position in Epizyme, Inc in Q3 2020 and held it in 1 quarter.
Jump Financial's Epizyme, Inc position peaked at $354K in Q3 2020.
137 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2020.

Based on Jump Financial's 13F filing for Q4 2020, filed 12 Feb 2021.